For R&D use only.

Regorafenib(BAY 73-4506)

  • Catalog NO.:A25020
  • CAS No. : 755037-03-7
  • Molecular Formula:C21H15ClF4N4O3
  • Molecular Weight: 482.82
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS

Product Details

CAS Number 755037-03-7 Appearance
Catalog Number A25020 MDL Number MFCD16038047
Molecular Formula C21H15ClF4N4O3 Molecular Weight 482.82
Boiling Point 513.4°C at 760 mmHg Melting Point
Flash Point Density
Synonyms 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea;Regorafenib
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Regorafenib, also known as BAY 73-4506 ; is a n orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. Regorafenib demonstrated to increase the overall survival of patients with metastatic colorectal cancer and has been approved by the US FDA on September 27, 2012.

Related Products

Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Regorafenib(BAY 73-4506)
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea;Regorafenib